Yali Bio

Categories
Founded

2021

Leadership
  • Yulin Lu, Co-Founder and CEO
Headquarters

San Francisco

Website

yali.bio

S2G North Star Interim Outcomes
  • Enhanced resilience and reduced waste in the food and agriculture supply chain Jump to footnote 1
Yali Biosciences is building a biotechnology platform for fats & lipids, a critical ingredient for nutrition, taste, and texture.

The company is focusing on structuring fats that emulate butterfat for applications in plant-based dairy and confectionery markets, and nutritional lipids that is bio-identical to human breast milk fats.

Open Positions

News

Footnotes

  1. S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.